Ebola from Bedside to Bench

Jonatan Ersching; Gabriel D Victora

doi:10.1016/j.cell.2019.05.021

Ebola from Bedside to Bench

Cell. 2019 May 30;177(6):1370-1372. doi: 10.1016/j.cell.2019.05.021.

Authors

Jonatan Ersching¹, Gabriel D Victora²

Affiliations

¹ Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA.
² Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA. Electronic address: victora@rockefeller.edu.

PMID: 31150616
DOI: 10.1016/j.cell.2019.05.021

Abstract

A longitudinal study by Davis et al. followed the evolution of antibody responses in four survivors of the 2014 Ebola outbreak treated in the United States and provides insight into the emergence of neutralizing antibodies long after convalescence.

Publication types

Comment

MeSH terms

Antibodies, Neutralizing
B-Lymphocytes
Ebolavirus / immunology*
Hemorrhagic Fever, Ebola*
Humans
Longitudinal Studies
United States

Substances

Antibodies, Neutralizing